BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 9082603)

  • 21. [Criteria for a pathogenetic approach to antiarrhythmic therapy in paroxysmal supraventricular reciprocal tachycardia].
    Chireĭkin LV; Shubik IuV; Tiunin MI
    Kardiologiia; 1990 Jun; 30(6):55-9. PubMed ID: 2214533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Supraventricular paroxysmal tachycardias during pregnancy: the therapeutic tactics and prognosis].
    Mravian SR; Petrukhin VA
    Klin Med (Mosk); 2007; 85(4):17-20. PubMed ID: 17564030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
    Koshumbaeva KM; Tulenov MT; Belokopit IN
    Klin Med (Mosk); 2002; 80(2):57-60. PubMed ID: 11898726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment of anti-arrhythmic efficacy of a domestic drug allapinin in patients with ischemic heart disease and cardiac arrhythmia].
    Zamotaev IuN; Kremnev IuA; Grinenko NA; Podshibiakin SE
    Klin Med (Mosk); 2003; 81(11):51-4. PubMed ID: 14689712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [How to treat patients with non-life-threatening arrhythmia symptoms].
    O'Hara G
    Can J Cardiol; 1994 Apr; 10(3):331-2. PubMed ID: 7512884
    [No Abstract]   [Full Text] [Related]  

  • 28. Current role of pharmacologic therapy for patients with paroxysmal supraventricular tachycardia.
    Basta M; Klein GJ; Yee R; Krahn A; Lee J
    Cardiol Clin; 1997 Nov; 15(4):587-97. PubMed ID: 9403162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The treatment of heart arrhythmia with the heart sympatholytic iproveratril].
    Barousch R
    Wien Klin Wochenschr; 1967 Nov; 79(46):856-60. PubMed ID: 4174474
    [No Abstract]   [Full Text] [Related]  

  • 30. Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia?
    Wiesfeld AC; Ansink JM; van Veldhuisen DJ; van Gelder IC
    Int J Cardiol; 2006 Feb; 107(1):140-1. PubMed ID: 15990183
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic possibilities in paroxysmal tachycardia with the use of the synthetic antihistaminic, 2-phenylbenzylaminomethylimidazoline].
    Nicita-Mauro V
    Folia Cardiol; 1967; 26(1):26-36. PubMed ID: 4383306
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of propafenone in emergency therapy].
    Liguori A; Pellegrino G; Di Ieso N; Piatto A; Ruggiero P; Scarnera P; Guardascione A
    Clin Ter; 1989 Dec; 131(5):307-14. PubMed ID: 2532584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias.
    Joshi PP; Deshmukh PK; Salkar RG
    J Assoc Physicians India; 1995 Aug; 43(8):529-31. PubMed ID: 8772970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regular supraventricular tachycardias associated with idiopathic atrial fibrillation.
    Gonzalez-Zuelgaray J; Perez A
    Am J Cardiol; 2006 Nov; 98(9):1242-4. PubMed ID: 17056338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic significance of exercise-induced atrial arrhythmias.
    Bunch TJ; Chandrasekaran K; Gersh BJ; Hammill SC; Hodge DO; Khan AH; Packer DL; Pellikka PA
    J Am Coll Cardiol; 2004 Apr; 43(7):1236-40. PubMed ID: 15063436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
    Hosokawa Y; Takano H; Ohno T; Takayama M; Takano T
    Angiology; 2008; 59(3):329-34. PubMed ID: 18388103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-arrhythmia treatment].
    Smolenskiĭ VS; Fomina IG
    Klin Med (Mosk); 1981 Aug; 59(8):95-104. PubMed ID: 6169875
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the influence of the antihistaminic Antistin on heart arrhythmias].
    Beckert J; Frings HD; Frost H; Nowy H
    Med Klin; 1966 Sep; 61(36):1429-31. PubMed ID: 4172429
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical contribution in the treatment of paroxysmal tachycardia].
    Tassone F
    Minerva Med; 1974 Sep; 65(60):3140-6. PubMed ID: 4153900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.